Salivary Biomarkers in Granulomatous Oral Lesions: Diagnostic Insights into Sarcoidosis and Crohn's Disease
International Journal of Drug Delivery Technology · 03.06.2026 · 16 (45s)
DOI: 10.25258/ijddt.16.45s.29 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 03.06.2026. Verfasst von Prateeksha Moharana und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Granulomatous oral lesions are difficult to diagnose, especially in conditions like sarcoidosis and Crohn's disease due to overlapping clinical and histopathological features. Biopsy remains the standard diagnostic tool but is invasive and not always practical. Saliva offers a non-invasive alternative, containing biomarkers that reflect both local and systemic immune responses. This study evaluates the role of salivary biomarkers in differentiating these conditions. Materials and Methods: Salivary samples from patients with granulomatous oral lesions associated with sarcoidosis and Crohn's disease were analyzed using quantitative RT-PCR to assess cytokines such as IFN-γ, TNF-α, IL-6, and IL-17. Bioinformatics tools, including STRING, Cytoscape, and KEGG pathway analysis, were used to explore molecular interactions and pathways.
Results
Sarcoidosis showed increased IFN-γ and TNF-α expression, indicating a Th1 response, while Crohn's disease demonstrated elevated IL-17 and IL-6, reflecting a Th17 profile. Network analysis identified a shared inflammatory core involving TNF-α and IL-6, along with disease-specific signaling differences.
Conclusion
Salivary biomarkers provide a promising non-invasive approach for differentiating granulomatous oral lesions. When combined with systems biology tools, they improve diagnostic accuracy and support the development of accessible, precision-based diagnostic strategies.
Zitieren
APA
Moharana, P., K, H. S., Samuvel, S., Basu, S., & Sekaran, S. (2026). Salivary Biomarkers in Granulomatous Oral Lesions: Diagnostic Insights into Sarcoidosis and Crohn's Disease. International Journal of Drug Delivery Technology, 16(45s). https://doi.org/10.25258/ijddt.16.45s.29
Vancouver
Moharana P, K HS, Samuvel S, Basu S, Sekaran S. Salivary Biomarkers in Granulomatous Oral Lesions: Diagnostic Insights into Sarcoidosis and Crohn's Disease. International Journal of Drug Delivery Technology. 2026;16(45s). doi:10.25258/ijddt.16.45s.29
BibTeX
@article{Moharana2026,
author = {Moharana, Prateeksha and K, Hema Shree and Samuvel, Sophia and Basu, Shama and Sekaran, Saravanan},
title = {Salivary Biomarkers in Granulomatous Oral Lesions: Diagnostic Insights into Sarcoidosis and Crohn's Disease},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {45s},
doi = {10.25258/ijddt.16.45s.29}
}
EUVIMED